Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1993-10-28
pubmed:abstractText
Oophorectomy (OOX) has been known to increase bone turnover, but its precise mechanism is not fully understood. In order to further investigate the mechanism, we determined insulinlike growth factor I (IGF-I) concentrations in serum and bone tissue and interleukin 1 (IL-1) release from spleen macrophages in oophorectomized rats because it has been demonstrated that IGF-I stimulates bone formation and IL-1 stimulates bone resorption. Female 8-week-old Wistar rats were divided into four groups: (1) control, (2) OOX, (3) OOX given estradiol, and (4) control given estradiol. Ten micrograms/kg of 17 beta-estradiol was given daily by subcutaneous injection. After 5 weeks of treatment, IGF-I concentrations in the extract from right femur and in serum were determined by specific radioimmunoassay. IL-1 activity released from lipopolysaccharide (LPS)-stimulated spleen macrophages was determined by bioassay. IGF-I contents in the femur and IGF-I concentrations in serum in oophorectomized rats were significantly higher than those in control rats. Treatment by estradiol inhibited the increase in IGF-I concentrations both in femur and in serum. IL-1 release from LPS-stimulated spleen macrophages in oophorectomized rats was increased, and treatment by estradiol also inhibited the stimulated IL-1 release. The ash weights and the calcium contents of left femur in oophorectomized rats were lower than those in control rats. These results suggest that both IGF-I and IL-1 may be involved in the mechanism of the regulation of bone turnover in oophorectomized rats.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0171-967X
pubmed:author
pubmed:issnType
Print
pubmed:volume
53
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
111-6
pubmed:dateRevised
2003-11-14
pubmed:meshHeading
pubmed-meshheading:8402318-Animals, pubmed-meshheading:8402318-Body Weight, pubmed-meshheading:8402318-Bone Development, pubmed-meshheading:8402318-Bone and Bones, pubmed-meshheading:8402318-Calcium, pubmed-meshheading:8402318-Cells, Cultured, pubmed-meshheading:8402318-Estradiol, pubmed-meshheading:8402318-Estrogen Replacement Therapy, pubmed-meshheading:8402318-Estrogens, pubmed-meshheading:8402318-Female, pubmed-meshheading:8402318-Femur, pubmed-meshheading:8402318-Injections, Subcutaneous, pubmed-meshheading:8402318-Insulin-Like Growth Factor I, pubmed-meshheading:8402318-Interleukin-1, pubmed-meshheading:8402318-Macrophages, pubmed-meshheading:8402318-Osteocalcin, pubmed-meshheading:8402318-Ovariectomy, pubmed-meshheading:8402318-Radioimmunoassay, pubmed-meshheading:8402318-Rats, pubmed-meshheading:8402318-Rats, Wistar, pubmed-meshheading:8402318-Spleen
pubmed:year
1993
pubmed:articleTitle
Effects of estrogen replacement on insulin-like growth factor I concentrations in serum and bone tissue and on interleukin 1 secretion from spleen macrophages in oophorectomized rats.
pubmed:affiliation
Department of Geriatrics, Faculty of Medicine, University of Tokyo, Japan.
pubmed:publicationType
Journal Article